The chemical class of ZNF844 inhibitors encompasses diverse compounds that exert their inhibitory effects through various molecular mechanisms, ultimately modulating the activity of the ZNF844 protein. These inhibitors target key cellular processes and signaling pathways involved in transcriptional regulation, chromatin remodeling, and cellular homeostasis, thereby influencing the functional activity of ZNF844 in gene expression and cellular function.
One major class of inhibitors includes compounds that target epigenetic modifiers, such as histone deacetylases (HDACs) and DNA methyltransferases (DNMTs). HDAC inhibitors, like trichostatin A and vorinostat, disrupt the deacetylation of histone proteins, leading to alterations in chromatin structure and accessibility. Similarly, DNMT inhibitors like 5-azacytidine and RG108 prevent DNA methylation, thereby modulating the transcriptional activity of ZNF844 and its target genes by altering DNA methylation patterns.
Another class of inhibitors targets signaling pathways involved in cellular proliferation, survival, and differentiation. Compounds like rapamycin and LY294002 inhibit the mTOR and PI3K/AKT/mTOR pathways, respectively, which intersect with pathways regulated by ZNF844. By modulating these signaling cascades, these inhibitors can indirectly influence ZNF844-mediated transcriptional responses to extracellular stimuli or developmental cues.
Moreover, inhibitors targeting stress response pathways, such as MAPK and JNK inhibitors (e.g., PD98059 and SP600125), can affect cellular responses to environmental stressors or inflammatory stimuli, impacting ZNF844-mediated transcriptional regulation of stress-responsive genes.
Natural compounds like curcumin, with pleiotropic effects on cellular signaling pathways including NF-κB and Wnt/β-catenin, can indirectly influence ZNF844-mediated transcriptional regulation by modulating pathways involved in inflammation, immunity, and cell proliferation.
Overall, the chemical class of ZNF844 inhibitors comprises a diverse array of compounds that target various cellular processes and signaling pathways to modulate the activity of the ZNF844 protein. These inhibitors represent valuable tools for elucidating the functional roles of ZNF844 in gene regulation and cellular physiology, with implications for understanding its involvement in disease pathogenesis.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
17-AAG | 75747-14-7 | sc-200641 sc-200641A | 1 mg 5 mg | $66.00 $153.00 | 16 | |
Inhibits heat shock protein 90 (Hsp90), which may affect the stability or function of ZNF844 protein. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $149.00 $470.00 $620.00 $1199.00 $2090.00 | 33 | |
Inhibits histone deacetylase (HDAC), potentially altering chromatin structure and impacting ZNF844-mediated transcriptional regulation. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $132.00 $1064.00 | 115 | |
Inhibits the proteasome, leading to the degradation of proteins including those regulated by ZNF844, thus affecting its downstream functions. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $62.00 $155.00 $320.00 | 233 | |
Inhibits the mechanistic target of rapamycin (mTOR), which may indirectly affect ZNF844-mediated signaling pathways involved in cell growth and proliferation. | ||||||
Nutlin-3 | 548472-68-0 | sc-45061 sc-45061A sc-45061B | 1 mg 5 mg 25 mg | $56.00 $212.00 $764.00 | 24 | |
Inhibits the interaction between MDM2 and p53, potentially affecting ZNF844-regulated pathways through modulation of p53 activity. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $39.00 $90.00 | 212 | |
Inhibits the MAPK/ERK pathway by targeting MEK1/2, thereby potentially modulating downstream signaling pathways involving ZNF844. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $121.00 $392.00 | 148 | |
Inhibits phosphoinositide 3-kinase (PI3K), a key enzyme in the PI3K/AKT/mTOR pathway, which may influence ZNF844-mediated signaling pathways and cellular functions. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
Inhibits c-Jun N-terminal kinase (JNK), potentially modulating stress response pathways that intersect with ZNF844-regulated processes. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $36.00 $68.00 $107.00 $214.00 $234.00 $862.00 $1968.00 | 47 | |
Modulates various signaling pathways, including NF-κB and Wnt/β-catenin, which may intersect with ZNF844-mediated transcriptional regulation. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
Incorporates into DNA and inhibits DNA methyltransferase, potentially altering DNA methylation patterns associated with ZNF844-regulated gene expression. | ||||||